Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Summary

RATIONALE: Vaccines made from a person's dendritic cells mixed with tumor peptides and proteins may help the body build an effective immune response to kill tumor cells. Infusing the vaccine directly into the lymphatic system may cause a stronger immune response and kill more tumor cells. PURPOSE: This randomized phase I trial is studying the side effects and best dose of two dendritic cell vaccines in treating patients with stage III or stage IV melanoma.

Timeline

Start

2006-10

Primary completion

2012-05

Completion

2015-01

Drugs

Indications